Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche

Executive Summary

Myron Holubiak, general manager of the Plymouth Group IMS subsidiary, is rejoining Roche as president of the U.S. drug business. Holubiak was in marketing, health economics and product management at Roche before going off to start his own consulting firm 13 years ago. Holubiak sold that firm, Emron, to IMS in 1994 and stayed on as a senior IMS manager. Holubiak replaces Steve Sudovar, who left the company in late October. Both Sudovar and Holubiak began their careers within Roche and subsequently formed outside consulting businesses before being recruited back to the company by Roche CEO Patrick Zenner to run the U.S. drug business
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS033267

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel